Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT.

De Witte, T

Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT. [electronic resource] - Bone marrow transplantation 1991 - 83 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial

0268-3369


Bone Marrow Transplantation--adverse effects
Double-Blind Method
Europe--epidemiology
Graft Survival--drug effects
Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology
Hematopoiesis--drug effects
Humans
Immunologic Factors--pharmacology
Infection Control
Infections--etiology
Leukocyte Count--drug effects
Lymphocyte Depletion
Neutropenia--complications
Prospective Studies
Recombinant Proteins--pharmacology
T-Lymphocytes--immunology